D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 119 Citations 54,869 575 World Ranking 2182 National Ranking 1265

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Angelo M. De Marzo mainly investigates Prostate cancer, Prostate, Pathology, Cancer and Cancer research. His research in Prostate cancer intersects with topics in Immunology and PTEN. His Prostate study incorporates themes from Carcinogenesis, Inflammation, Lymph node and Small-cell carcinoma.

His Pathology research integrates issues from Telomere and Adenocarcinoma. His work on Tissue microarray, Metastasis and Androgen receptor is typically connected to TMPRSS2 as part of general Cancer study, connecting several disciplines of science. Angelo M. De Marzo focuses mostly in the field of Cancer research, narrowing it down to matters related to Disease and, in some cases, Epidemiology, Chronic infection and Pathological.

His most cited work include:

  • Overexpression of Hypoxia-inducible Factor 1α in Common Human Cancers and Their Metastases (2003 citations)
  • AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. (1567 citations)
  • c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. (1429 citations)

What are the main themes of his work throughout his whole career to date?

Angelo M. De Marzo mostly deals with Prostate cancer, Prostate, Cancer research, Internal medicine and Pathology. Cancer covers he research in Prostate cancer. He has included themes like Biopsy and Immunology in his Prostate study.

The Cancer research study combines topics in areas such as DNA methylation, Cancer cell, Molecular biology, Metastasis and Androgen receptor. In his work, Disease and Single-nucleotide polymorphism is strongly intertwined with Oncology, which is a subfield of Internal medicine. He combines subjects such as Fluorescence in situ hybridization and Adenocarcinoma with his study of Pathology.

He most often published in these fields:

  • Prostate cancer (76.40%)
  • Prostate (49.89%)
  • Cancer research (34.38%)

What were the highlights of his more recent work (between 2016-2021)?

  • Prostate cancer (76.40%)
  • Prostate (49.89%)
  • Cancer research (34.38%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Prostate cancer, Prostate, Cancer research, Internal medicine and Cancer. His Prostate cancer study integrates concerns from other disciplines, such as Inflammation, Metastasis, PTEN and Pathology. His Metastasis research incorporates elements of Biochemical recurrence and Tumor progression.

His work deals with themes such as Telomere, Stromal cell, Tissue microarray and Immunophenotyping, which intersect with Prostate. His study focuses on the intersection of Cancer research and fields such as Immunotherapy with connections in the field of CD8. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.

Between 2016 and 2021, his most popular works were:

  • Clinical implications of PTEN loss in prostate cancer (169 citations)
  • The inflammatory microenvironment and microbiome in prostate cancer development (113 citations)
  • Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer (76 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Angelo M. De Marzo focuses on Prostate cancer, Prostate, Cancer research, Cancer and Pathology. His Prostate cancer research includes elements of Metastasis, PTEN and Tissue microarray. To a larger extent, Angelo M. De Marzo studies Internal medicine with the aim of understanding Prostate.

His biological study spans a wide range of topics, including Hormone therapy, Carcinoma, Gene knockdown and Gene mutation. His research integrates issues of Immunohistochemistry, Regulation of gene expression, Prospective cohort study and Biopsy in his study of Cancer. His work carried out in the field of Pathology brings together such families of science as Germline mutation, Somatic hypermutation and Primary Gleason Pattern.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Overexpression of Hypoxia-inducible Factor 1α in Common Human Cancers and Their Metastases

Hua Zhong;Angelo M. De Marzo;Erik Laughner;Michael Lim.
Cancer Research (1999)

3488 Citations

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Emmanuel S. Antonarakis;Changxue Lu;Hao Wang;Brandon Luber.
The New England Journal of Medicine (2014)

2402 Citations

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Ping Gao;Irina Tchernyshyov;Tsung Cheng Chang;Yun Sil Lee.
Nature (2009)

2037 Citations

Inflammation in prostate carcinogenesis

Angelo M. De Marzo;Angelo M. De Marzo;Elizabeth A. Platz;Siobhan Sutcliffe;Jianfeng Xu.
Nature Reviews Cancer (2007)

1904 Citations

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn.
Proceedings of the National Academy of Sciences of the United States of America (2004)

1549 Citations

Proliferative Inflammatory Atrophy of the Prostate : Implications for Prostatic Carcinogenesis

Angelo M. De Marzo;Valerie L. Marchi;Jonathan I. Epstein;William G. Nelson.
American Journal of Pathology (1999)

1108 Citations

α-methylacyl-CoA racemase: A new molecular marker for prostate cancer

Jun Luo;Shan Zha;Wesley R. Gage;Thomas A. Dunn.
Cancer Research (2002)

781 Citations

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo.
Cancer Research (1999)

699 Citations

Pathological and molecular aspects of prostate cancer.

Angelo M DeMarzo;William G Nelson;William B Isaacs;Jonathan I Epstein.
The Lancet (2003)

660 Citations

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.

J. Carpten;N. Nupponen;S. Isaacs;R. Sood.
Nature Genetics (2002)

654 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Angelo M. De Marzo

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 188

Liang Cheng

Liang Cheng

Indiana University

Publications: 127

Arul M. Chinnaiyan

Arul M. Chinnaiyan

University of Michigan–Ann Arbor

Publications: 123

Peter S. Nelson

Peter S. Nelson

Fred Hutchinson Cancer Research Center

Publications: 119

Massimo Loda

Massimo Loda

Cornell University

Publications: 112

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 106

Rodolfo Montironi

Rodolfo Montironi

Marche Polytechnic University

Publications: 100

Lorelei A. Mucci

Lorelei A. Mucci

Harvard University

Publications: 99

George J. Netto

George J. Netto

University of Alabama at Birmingham

Publications: 98

Pedram Argani

Pedram Argani

Johns Hopkins University

Publications: 95

William B. Isaacs

William B. Isaacs

Johns Hopkins University

Publications: 84

Antonio Lopez-Beltran

Antonio Lopez-Beltran

University of Córdoba

Publications: 80

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 76

Francesca Demichelis

Francesca Demichelis

University of Trento

Publications: 76

Ralph H. Hruban

Ralph H. Hruban

Johns Hopkins University School of Medicine

Publications: 76

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 72

Trending Scientists

Hongqing Zhang

Hongqing Zhang

Dalian University of Technology

Hong X. Tang

Hong X. Tang

Yale University

Murat Arcak

Murat Arcak

University of California, Berkeley

Dennis Nordlund

Dennis Nordlund

SLAC National Accelerator Laboratory

Erik Fridell

Erik Fridell

Chalmers University of Technology

Mihael H. Polymeropoulos

Mihael H. Polymeropoulos

Vanda Pharmaceuticals (United States)

Harsh Nayyar

Harsh Nayyar

Panjab University

Howard Ferris

Howard Ferris

University of California, Davis

Hans-Georg Kräusslich

Hans-Georg Kräusslich

Heidelberg University

Menzo J. E. Havenga

Menzo J. E. Havenga

Batavia Biosciences (Netherlands)

Kiyoshi Suyehiro

Kiyoshi Suyehiro

Japan Agency for Marine-Earth Science and Technology

Michael Gleeson

Michael Gleeson

Loughborough University

Tuulikki Sokka

Tuulikki Sokka

University of Eastern Finland

Todd R. Risley

Todd R. Risley

University of Kansas

Shin Mineshige

Shin Mineshige

Kyoto University

Evan D. Skillman

Evan D. Skillman

University of Minnesota

Something went wrong. Please try again later.